Correlation Between Vertex Pharmaceuticals and BB Biotech

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and BB Biotech AG, you can compare the effects of market volatilities on Vertex Pharmaceuticals and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and BB Biotech.

Diversification Opportunities for Vertex Pharmaceuticals and BB Biotech

0.61

Correlation Coefficient

Vertex Pharmaceuticals  BB Biotech

Poor diversification

The 3 months correlation between Vertex and BBZA is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and BB Biotech go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and BB Biotech

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to generate 1.0 times more return on investment than BB Biotech. However, Vertex Pharmaceuticals is 1.0 times more volatile than BB Biotech AG. It trades about 0.0 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.03 per unit of risk. If you would invest  44,675  in Vertex Pharmaceuticals Incorporated on September 2, 2024 and sell it today you would lose (570.00) from holding Vertex Pharmaceuticals Incorporated or give up 1.28% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vertex Pharmaceuticals Incorpo  vs.  BB Biotech AG

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Vertex Pharmaceuticals and BB Biotech

The main advantage of trading using opposite Vertex Pharmaceuticals and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind Vertex Pharmaceuticals Incorporated and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.